Arbutus Biopharma Corporation (ABUS)
NASDAQ·Healthcare·Biotechnology
$4.17
-2.69%
Mkt Cap $830.78M
Next Earnings
In 13 daysTue, May 12, 2026
EPS Estimate
-$0.03
1 analysts
Revenue Estimate
$650.00K
Last quarter: beat by +71.47% on EPS, +71.03% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$830.78M
P/E
—
Fwd P/E
—
P/S
58.99
Rev TTM
—
EPS TTM
-$0.18